Literature DB >> 15295043

Treatment of heart failure with spironolactone--trial and tribulations.

John J V McMurray1, Eileen O'Meara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15295043     DOI: 10.1056/NEJMp048144

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Monitoring renal function in hypertension.

Authors:  Una Martin; Jamie J Coleman
Journal:  BMJ       Date:  2006-10-28

2.  Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff.

Authors:  Munir Pirmohamed
Journal:  Wien Klin Wochenschr       Date:  2010-02       Impact factor: 1.704

3.  Aldosterone antagonists in systolic heart failure.

Authors:  Adrienne J Lindblad; G Michael Allan
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

Review 4.  A landmark for popperian epidemiology: refutation of the randomised Aldactone evaluation study.

Authors:  Elard Koch; Alvaro Otarola; Aida Kirschbaum
Journal:  J Epidemiol Community Health       Date:  2005-11       Impact factor: 3.710

Review 5.  Eplerenone : a pharmacoeconomic review of its use in patients with post-myocardial infarction heart failure.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Spironolactone and chlorthalidone-old drugs, new uses-but approach with caution.

Authors:  Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2022-02-25       Impact factor: 5.992

Review 7.  Hyperkalemia in patients with heart failure: incidence, prevalence, and management.

Authors:  Akshay S Desai
Journal:  Curr Heart Fail Rep       Date:  2009-12

8.  Evidentiary Pluralism as a Strategy for Research and Evidence-Based Practice in Rehabilitation Psychology.

Authors:  Jalie A Tucker; Geoffrey M Reed
Journal:  Rehabil Psychol       Date:  2008-08

Review 9.  The challenges of enrolling older adults into intervention studies.

Authors:  Nancy A Knechel
Journal:  Yale J Biol Med       Date:  2013-03-12

10.  Similar to spironolactone, oxymatrine is protective in aldosterone-induced cardiomyocyte injury via inhibition of calpain and apoptosis-inducing factor signaling.

Authors:  Ting-Ting Xiao; Yuan-Yuan Wang; Yan Zhang; Cong-Hui Bai; Xiang-Chun Shen
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.